Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of TADALIZZ 20 versus Cialis under fed conditions in healthy Thai men
TCTR20261029002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tadalafil in erectile dysfunction (ED) (2 arms), sponsored by International Bio Service. Primary endpoints: Maximum plasma concentration (Cmax), AUC0-tlast and 1 more. Planned start Apr 2027; status: not yet recruiting.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on TCTR20261029002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261029002.